This workshop will focus on how to develop business opportunities from genomic research and biodata. It is aimed at professionals involved in the translation of early-stage technologies who want to further develop their knowledge on the commercial paths to the application of genomics into healthcare products and services.

Over the past decade, we have seen an acceleration in genomics research and its application to biomedical technologies. However, the route to commercialising early-stage genomics-based opportunities is not ‘set in stone’; and commercial drivers such as the regulatory environment, health economics clarity or technological advances are only emerging. Therefore, there is a need for a community-building approach to share experience, best practice and learn from business and partnership models as they develop.

The workshop will bring together attendees and experts to discuss and share practical advice on developing opportunities for precision medicine. Ultimately, the impact of genomic medicine on patients will be driven not only by improvements in stratification tools but also by the availability of new targeted drugs. In this workshop, we will therefore consider a wide range of applications relevant to precision medicine.

For example we will address questions such as:

  • What kind of business models are emerging to generate value from genomics in the pharmaceutical and clinical diagnostic space?
  • What are the partnering opportunities for academia, SME, pharma and biotech along a drug R&D axis powered by genomics?
  • How do commercial drivers differ for developing diagnostic, companion diagnostics or screening products?
  • How to navigate the complexities of open source software licenses for the benefit of innovation?
  • What is the current regulatory environment for developing genomic medicine products and how does it affect commercial pathways?
  • What opportunities might be arising from technical advances such as artificial intelligence, sequencing miniaturisation, mobile technologies or large population health genomic initiatives? 

We have invited prominent entrepreneurs, investors and business development professionals in this field to lead this interactive workshop. We also encourage participants to bring their own commercialisation challenges for discussion with the group.

Who should attend?

If you are working as a business development manager, a technology transfer professional, investment analyst, innovation funder, or you are an entrepreneur or a researcher actively involved in translation and commercialisation; this course is for you. The workshop is designed for 40 participants to maximise discussions.

Through this workshop we aim to build a supportive network of professionals working on the translation and commercialisation of genomics and informatics.

Learning outcomes:
After this workshop, participants should be able to:

  • Plan an exploitation strategy that considers the impact on future research and clinical adoption.
  • Navigate the regulatory environment that frames the implementation of genomics tools and diagnostics in the clinic.
  • Avoid pitfalls and work within the 'culture landscape' of software licenses and innovation framework.
  • Consider a variety of business models and partnerships around biodata, bioinformatics or genomic information.
  • Access a network of engaged professionals for further advice and sharing best practice.

Feedback on 2016 course

"Really excellent programme. I hope you will run it again as would recommend it to colleagues here"

"Thank you for organising the course. It was very well organised and I found it very useful and helpful"

The first of these courses was held in December 2016, click here to find out more.

Bursary & Application Deadline:
11 September 2018


Already registered?
Login to your account.


Email the Event Organiser
(or call us: +44 (0)1223 495100

Hashtag: #CGR18